Netherlands· NL-63de531189f6
Citanest 3% - Octapressine DENTAL, injectievloeistof voor perineurale toediening 30 mg/ml + 0,54 microgram/ml
A prilocain, kombinationen product containing felypressine + prilocaïnehydrochloride, registered in Netherlands by Dentsply DeTrey GmbH. The same ATC class is registered in 7 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Prilocain, kombinationen is registered in 7 of 19 countries.
Countries holding a registration under ATC N01BB54 (prilocain, kombinationen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 3 of them publish a price we can compare per daily dose
Prilocain, kombinationen · ATC N01BB54
7 / 19 countries
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FELYPRESSINE + PRILOCAÏNEHYDROCHLORIDE
- Manufacturer
- Dentsply DeTrey GmbH
- Country
- Netherlands (NL)
- ATC code
- N01BB54
- ATC class
- Prilocain, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id07824
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Prilocain, kombinationen in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCitanest 3% with Octapressin Dental 0.054units/1.8ml solution for injection self aspirating cartridgesDentsply Ltd
- IcelandCitanest Dental OctapressinDENTSPLY DeTrey GmbH*
- FinlandCitanest Dental OctapressinDENTSPLY DeTrey GmbH
- IrelandCitanest with Octapressin Dental, Prilocaine Hydrochloride 3 % w/v, Felypressin 0.54 micrograms/ml Solution for InjectionDENTSPLY DeTrey GmbH
- NorwayCitanest Dental OctapressinDentsply DeTrey GmbH
- SwedenCitanest Dental Octapressin 30 mg/ml + 0,54 mikrogram/ml Injektionsvätska, lösningDentsply DeTrey GmbH
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Denmark · Citanest Dental Octapressin
- Finland · Citanest Dental Octapressin
- United Kingdom (Northern Ireland) · Citanest With Octapressin
- Ireland · Citanest With Octapressin Dental
- Iceland · Citanest Dental Octapressin
- Norway · Citanest Dental Octapressin
- Sweden · Citanest Dental Octapressin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3554b9d4-e465-4946-8fc7-fcee98ad35c5 GET /v1/drugs/3554b9d4-e465-4946-8fc7-fcee98ad35c5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Perineuraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h07824_smpc.pdf",
"strength": null,
"atc_label": "Prilocaine, Combinations",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg07824",
"excipients": [
"NATRIUMCHLORIDE",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"FELYPRESSINE",
"PRILOCAÏNEHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h07824.pdf",
"authorised_at": "1984/01/30",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "07824",
"additional_monitoring": "N"
}See everything about prilocain, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.